{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:13:55Z","timestamp":1792178035751,"version":"4.4.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.clineuro.2006.07.003","type":"journal-article","created":{"date-parts":[[2006,9,2]],"date-time":"2006-09-02T07:22:32Z","timestamp":1157181752000},"page":"188-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing"],"prefix":"10.1016","volume":"109","author":[{"given":"Jan","family":"Schindeh\u00fctte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Trenkwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clineuro.2006.07.003_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s002130050755","article-title":"Ziprasidone 40 and 120mg\/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4 week placebo-controlled trial","volume":"140","author":"Keck","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.clineuro.2006.07.003_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00004714-199808000-00009","article-title":"An exploratory haloperidole-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder","volume":"18","author":"Goff","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clineuro.2006.07.003_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","article-title":"Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile","volume":"425","author":"Schmidt","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.clineuro.2006.07.003_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/070674370404900119","article-title":"Ziprasidone in Parkinson's disease psychosis","volume":"49","author":"Connemann","year":"2004","journal-title":"Can J Psychiatry"},{"issue":"3","key":"10.1016\/j.clineuro.2006.07.003_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/hup.682","article-title":"Parenteral ziprasidone: a new atypical neuroletic for emergency treatment of psychosis in Parkinson's disease","volume":"20","author":"Oechsner","year":"2005","journal-title":"Hum Psychopharmacol"},{"issue":"7","key":"10.1016\/j.clineuro.2006.07.003_bib6","first-page":"661","article-title":"Quetiapine and ziprasidone in the treatment of the psychotic disorders in Parkinson's disease","volume":"39","author":"Lopez Del Val","year":"2004","journal-title":"Rev Neurol"},{"issue":"3","key":"10.1016\/j.clineuro.2006.07.003_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.wnf.0000164297.91643.ff","article-title":"Use of ziprasidone in parkinsonian patients with psychosis","volume":"28","author":"Gomez-Esteban","year":"2005","journal-title":"Clin Neuropharmacol"},{"issue":"Pt. 4","key":"10.1016\/j.clineuro.2006.07.003_bib8","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/brain\/awh102","article-title":"Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model","volume":"127","author":"de la Fuente-Fernandez","year":"2004","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.clineuro.2006.07.003_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/02699059209029668","article-title":"Fluoxeptine improves emotional incontinence","volume":"6","author":"Seliger","year":"1992","journal-title":"Brain Inj"},{"issue":"10","key":"10.1016\/j.clineuro.2006.07.003_bib10","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archneur.1984.04050210093023","article-title":"Pathological laughing and crying treated with levodopa","volume":"41","author":"Udaka","year":"1984","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clineuro.2006.07.003_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/hup.578","article-title":"Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson\u2018s disease: a diagnostic challenge","volume":"19","author":"Gray","year":"2004","journal-title":"Hum Psychopharmacol Clin Exp"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846706001156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846706001156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:26:05Z","timestamp":1759587965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846706001156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0303846706001156"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2006.07.003","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2006.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}